Choksi Asia (BSE 530427)₹202.95−6.02%Medical Equipment & Supplies
In the Mar 2026 quarter (standalone), Choksi Asia reported sales of ₹11.81 Cr, down 2.4% from Mar 2025, and net profit of ₹0.74 Cr, up 5.7% year on year. For the year to Mar 2026, sales were ₹49.10 Cr and net profit ₹5.32 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.39 | 0.51 | 3.03 | 0.14 | 1.36 | 8.39 | 8.64 | 12.10 | 11.85 | 13.24 | 12.20 | 11.81 |
| Expenses | 0.78 | 1.16 | 3.24 | 0.57 | 1.10 | 7.48 | 8.99 | 10.95 | 10.54 | 11.72 | 10.50 | 9.89 |
| Operating Profit | −0.38 | −0.64 | −0.20 | −0.42 | 0.29 | 0.98 | −0.29 | 1.25 | 1.40 | 1.61 | 1.80 | 2.01 |
| OPM % | −92.5% | −121.1% | −6.2% | −273.3% | 20.5% | 11.6% | −3.2% | 10.2% | 11.7% | 12.1% | 14.6% | 16.9% |
| Other Income | 0.37 | 0.19 | 0.46 | 0.24 | 0.18 | 0.23 | 0.81 | 0.22 | 0.28 | 0.28 | 0.51 | 0.30 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.11 | 0.08 | 0.09 | 0.13 | 0.08 | 0.08 |
| Depreciation | 0.05 | 0.05 | 0.04 | 0.03 | 0.05 | 0.05 | 0.04 | 0.03 | 0.05 | 0.09 | 0.06 | 0.08 |
| Profit before tax | −0.04 | −0.48 | 0.24 | −0.21 | 0.44 | 1.05 | 0.38 | 1.35 | 1.53 | 1.68 | 2.18 | 2.16 |
| Tax % | 0.0% | 0.0% | −174.0% | −255.0% | 16.2% | 36.5% | 40.5% | 47.0% | 28.9% | 19.1% | 1.4% | 65.1% |
| Net Profit | −0.02 | −0.46 | 0.62 | 0.30 | 0.35 | 0.64 | 0.21 | 0.70 | 1.06 | 1.34 | 2.12 | 0.74 |
| EPS (Rs) | −0.09 | −1.22 | 1.63 | 0.80 | 0.93 | 1.68 | 0.57 | 1.83 | 1.89 | 2.38 | 3.75 | 1.33 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 45.75 | 27.15 | 22.99 | 17.26 | 15.93 | 11.12 | 2.45 | 0.76 | 15.93 | 36.82 | 49.10 | 49.10 |
| Expenses | 43.57 | 26.40 | 21.83 | 17.82 | 17.47 | 12.89 | 3.94 | 2.22 | 16.08 | 33.29 | 42.65 | 42.65 |
| Operating Profit | 2.57 | 0.96 | 1.32 | −0.43 | −1.43 | −1.70 | −1.47 | −1.45 | −0.03 | 3.82 | 6.82 | 6.82 |
| OPM % | 5.6% | 3.5% | 5.7% | −2.4% | −8.9% | −15.2% | −59.3% | −187.0% | −0.1% | 10.3% | 13.8% | 13.9% |
| Other Income | 0.39 | 0.42 | 0.73 | 1.63 | 1.05 | 4.57 | 1.13 | 1.15 | 2.09 | 1.57 | 1.39 | 1.37 |
| Interest | 0.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.39 | 0.47 | 0.41 | 0.38 |
| Depreciation | 0.40 | 0.40 | 0.23 | 0.22 | 0.18 | 0.20 | 0.18 | 0.17 | 0.17 | 0.17 | 0.28 | 0.28 |
| Profit before tax | 2.19 | 1.00 | 1.84 | 1.02 | −0.54 | 2.71 | −0.50 | −0.45 | 1.51 | 4.74 | 7.51 | 7.55 |
| Tax % | 0.9% | 22.2% | 30.0% | 14.8% | 5.7% | 29.2% | −12.3% | 6.8% | 7.3% | 34.2% | 28.9% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 2.16 | 0.76 | 1.28 | 0.85 | −0.55 | 1.90 | −0.41 | −0.47 | 1.38 | 3.09 | 5.32 | 5.26 |
| EPS (Rs) | 5.58 | 1.98 | 3.32 | 2.22 | −1.45 | 4.91 | −1.09 | −1.24 | 3.57 | 7.97 | 9.38 | 9.35 |
| Dividend payout % | 17.9% | 38.0% | 22.6% | 22.7% | 0.0% | 51.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.89 | 3.91 | 3.91 | 3.89 | 3.91 | 3.91 | 3.91 | 3.91 | 3.90 | 5.70 | 5.72 | 11.11 |
| Reserves | 8.28 | 9.98 | 10.95 | 11.89 | 12.38 | 11.59 | 13.52 | 12.08 | 11.63 | 22.34 | 25.77 | 31.02 |
| Borrowings | 6.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.24 | 10.20 | 1.93 |
| Other Liabilities | 17.14 | 22.51 | 20.88 | 20.97 | 21.00 | 20.15 | 3.81 | 2.43 | 2.54 | 4.54 | 5.54 | 3.42 |
| Total Liabilities | 35.76 | 36.40 | 35.74 | 36.75 | 37.29 | 35.65 | 21.24 | 18.42 | 18.07 | 41.82 | 47.23 | 47.48 |
| Fixed Assets | 8.80 | 8.49 | 8.02 | 7.80 | 7.50 | 7.33 | 6.11 | 5.94 | 5.78 | 14.93 | 15.57 | 16.38 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 3.89 | 7.51 | 5.38 | 2.94 | 6.89 | 0.79 | 3.36 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 26.96 | 24.02 | 20.21 | 23.57 | 26.85 | 21.43 | 14.34 | 9.12 | 12.29 | 26.89 | 31.66 | 31.10 |
| Inventories | 11.89 | 9.76 | 6.86 | 4.09 | 5.76 | 3.87 | 0.89 | 0.33 | 2.69 | 5.40 | 8.83 | 9.14 |
| Trade receivables | 9.67 | 7.97 | 5.87 | 6.71 | 4.89 | 4.70 | 0.99 | 0.59 | 0.37 | 3.57 | 8.30 | 9.42 |
| Cash & equivalents | 0.66 | 1.51 | 3.16 | 8.30 | 10.94 | 8.17 | 7.32 | 3.30 | 4.13 | 11.77 | 10.01 | 6.56 |
| Total Assets | 35.76 | 36.40 | 35.74 | 36.75 | 37.29 | 35.65 | 21.24 | 18.42 | 18.07 | 41.82 | 47.23 | 47.48 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 10.68 | 7.96 | 1.66 | 5.51 | 2.43 | −2.53 | −2.83 | −0.57 | −2.53 | 2.69 | −2.88 | 0.75 |
| Cash from investing activity | −0.13 | −0.18 | −0.02 | 0.00 | 0.59 | −0.02 | 1.97 | −2.50 | 3.36 | 1.53 | 0.64 | 0.09 |
| Cash from financing activity | −11.44 | −6.89 | 0.00 | −0.34 | −0.34 | −0.23 | 0.00 | −0.97 | 0.00 | 0.46 | −1.19 | −3.39 |
| Net cash flow | −0.95 | 0.87 | 1.66 | 5.15 | 2.65 | −2.78 | −0.86 | −4.03 | 0.84 | 4.68 | −3.44 | −2.59 |
| Capex | 0.11 | 0.16 | 0.00 | 0.00 | 0.06 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.82 | 1.08 |
| Free cash flow | 10.51 | 7.75 | 1.63 | 5.48 | 2.99 | −2.52 | −0.85 | −0.55 | −2.51 | 2.78 | −3.68 | −0.34 |
| CFO / OP % | 578.0% | 308.0% | 174.0% | 422.0% | −581.0% | 177.0% | 153.0% | 25.0% | 175.0% | −13,400.0% | −75.0% | 11.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 34 | 64 | 80 | 107 | 104 | 109 | 34 | 90 | 181 | 83 | 83 | 71 |
| Inventory days | 47 | 101 | 125 | 89 | 156 | 113 | 34 | 71 | 1,971 | 150 | 106 | 86 |
| Days payable | 54 | 210 | 350 | 407 | 503 | 531 | 45 | 27 | 88 | 46 | 39 | 14 |
| Cash conversion cycle | 26 | −45 | −146 | −211 | −244 | −311 | 22 | 133 | 2,064 | 185 | 149 | 142 |
| Working capital days | 5 | −11 | −74 | −114 | −138 | −177 | 78 | 382 | 2,362 | 132 | 139 | 135 |
| ROCE % | 6.0% | 15.7% | 6.6% | 9.7% | 5.7% | −3.3% | 16.4% | −2.9% | −2.8% | 7.2% | 13.3% | 18.5% |
For the Mar 2026 quarter, Choksi Asia reported sales of ₹11.81 Cr, down 2.4% year on year and net profit of ₹0.74 Cr, up 5.7% year on year. The operating margin was 16.9%.
Choksi Asia's sales for the year to Mar 2026 were ₹49.10 Cr; over the last twelve months they were ₹49.10 Cr.
Net profit for the year to Mar 2026 was ₹5.32 Cr, and ₹5.26 Cr over the last twelve months. Earnings per share over the same trailing period were ₹9.35.
Choksi Asia reported borrowings of ₹1.93 Cr at Mar 2026, against cash and equivalents of ₹6.56 Cr.
Cash from operations was ₹0.75 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹0.34 Cr.